{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T21:40:46Z","timestamp":1770673246598,"version":"3.49.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005972","name":"Deutsche Krebshilfe","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ctro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Translational Radiation Oncology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ctro.2025.101079","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T10:40:29Z","timestamp":1763635229000},"page":"101079","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Impact of tumour proximity to organs-at-risk in adaptive MR-guided SBRT for central lung tumours and metastases"],"prefix":"10.1016","volume":"57","author":[{"given":"Sina","family":"Mansoorian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ala Sami","family":"Ismail Salameh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Hamm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5725-9959","authenticated-orcid":false,"given":"Svenja","family":"Hering","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"Kauffmann-Guerrero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helmut","family":"Weingandt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa","family":"da Silva Mendes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7936-9753","authenticated-orcid":false,"given":"Jan","family":"Hofmaier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Marschner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nina-Sophie","family":"Schmidt-Hegemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1707-4068","authenticated-orcid":false,"given":"Guillaume","family":"Landry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claus","family":"Belka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8709-7252","authenticated-orcid":false,"given":"Stefanie","family":"Corradini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3779-1398","authenticated-orcid":false,"given":"Chukwuka","family":"Eze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ctro.2025.101079_b0005","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/JTO.0000000000000453","article-title":"Stereotactic ablative radiotherapy for centrally located early stage non-small-cell lung cancer: what we have learned","volume":"10","author":"Chang","year":"2015","journal-title":"J. Thorac. Oncol."},{"issue":"30","key":"10.1016\/j.ctro.2025.101079_b0010","doi-asserted-by":"crossref","first-page":"4833","DOI":"10.1200\/JCO.2006.07.5937","article-title":"Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer","volume":"24","author":"Timmerman","year":"2006","journal-title":"J. Clin. Oncol."},{"issue":"1051","key":"10.1016\/j.ctro.2025.101079_b0015","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20150036","article-title":"LungTech, an EORTC Phase II trial of stereotactic body radiotherapy for centrally located lung tumours: a clinical perspective","volume":"88","author":"Adebahr","year":"2015","journal-title":"Br. J. Radiol."},{"issue":"12","key":"10.1016\/j.ctro.2025.101079_b0020","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1016\/j.jtho.2024.09.1386","article-title":"Appropriate use criteria (AUC) for the management of non-small cell lung cancer in a central\/ultra-central location: guidelines from the American radium society","volume":"19","author":"Park","year":"2024","journal-title":"J. Thorac. Oncol."},{"issue":"4","key":"10.1016\/j.ctro.2025.101079_b0025","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.ijrobp.2019.03.035","article-title":"Role of on-table plan adaptation in MR-guided ablative radiation therapy for central lung tumors","volume":"104","author":"Finazzi","year":"2019","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"1","key":"10.1016\/j.ctro.2025.101079_b0030","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.adro.2018.10.003","article-title":"Stereotactic MR-guided online adaptive radiation therapy (SMART) for ultracentral thorax malignancies: results of a phase 1 trial","volume":"4","author":"Henke","year":"2019","journal-title":"Adv. Radiat. Oncol."},{"key":"10.1016\/j.ctro.2025.101079_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2023.03.011","article-title":"To fly or not to fly: Stereotactic MR-guided adaptive radiotherapy effectively treats ultracentral lung tumors with favorable long-term outcomes","volume":"179","author":"Regnery","year":"2023","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ctro.2025.101079_b0040","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.617681","article-title":"Initial clinical experience of MR-guided radiotherapy for non-small cell lung cancer","volume":"11","author":"Crockett","year":"2021","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.ctro.2025.101079_b0045","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13014-022-02021-6","article-title":"Dosimetric benefit of MR-guided online adaptive radiotherapy in different tumor entities: liver, lung, abdominal lymph nodes, pancreas and prostate","volume":"17","author":"Nierer","year":"2022","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.ctro.2025.101079_b0050","article-title":"The role of online MR-guided multi-fraction stereotactic ablative radiotherapy in lung tumours","volume":"45","author":"Hering","year":"2024","journal-title":"Clin. Transl. Radiat. Oncol."},{"key":"10.1016\/j.ctro.2025.101079_b0055","article-title":"Stereotactic body radiotherapy of central lung tumours using a 1.5 T MR-linac: First clinical experiences","volume":"45","author":"Merckel","year":"2024","journal-title":"Clin Transl. Radiat. Oncol."},{"issue":"1","key":"10.1016\/j.ctro.2025.101079_b0060","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3390\/tomography10010013","article-title":"Accelerated hypofractionated magnetic resonance guided adaptive radiation therapy for ultracentral lung tumors","volume":"10","author":"La Rosa","year":"2024","journal-title":"Tomography."},{"key":"10.1016\/j.ctro.2025.101079_b0065","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1061854","article-title":"Adaptive hypofractionted and stereotactic body radiotherapy for lung tumors with real-time MRI guidance","volume":"13","author":"Bryant","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ctro.2025.101079_b0070","first-page":"98","article-title":"Technical design and concept of a 0.35 T MR-Linac","volume":"18","author":"Kl\u00fcter","year":"2019","journal-title":"Clin Transl. Radiat. Oncol."},{"issue":"3","key":"10.1016\/j.ctro.2025.101079_b0075","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.semradonc.2014.02.008","article-title":"The ViewRay System: magnetic resonance\u2013guided and controlled radiotherapy","volume":"24","author":"Mutic","year":"2014","journal-title":"Semin. Radiat. Oncol."},{"issue":"1","key":"10.1016\/j.ctro.2025.101079_b0080","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13014-022-02011-8","article-title":"MR-guided radiotherapy in node-positive non-small cell lung cancer and severely limited pulmonary reserve: a report proposing a new clinical pathway for the management of high-risk patients","volume":"17","author":"Eze","year":"2022","journal-title":"Radiat. Oncol."},{"issue":"5","key":"10.1016\/j.ctro.2025.101079_b0085","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.prro.2023.04.003","article-title":"Consensus quality measures and dose constraints for lung cancer from the veterans affairs radiation oncology quality surveillance program and ASTRO expert panel","volume":"13","author":"Puckett","year":"2023","journal-title":"Pract. Radiat. Oncol."},{"issue":"1","key":"10.1016\/j.ctro.2025.101079_b0095","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ijrobp.2021.09.027","article-title":"A story of hypofractionation and the table on the wall","volume":"112","author":"Timmerman","year":"2022","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"4","key":"10.1016\/j.ctro.2025.101079_b0100","doi-asserted-by":"crossref","first-page":"e355","DOI":"10.1016\/j.prro.2021.03.005","article-title":"Organ at risk dose constraints in SABR: a systematic review of active clinical trials","volume":"11","author":"Gerhard","year":"2021","journal-title":"Pract. Radiat. Oncol."},{"issue":"1","key":"10.1016\/j.ctro.2025.101079_b0105","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ijrobp.2020.01.009","article-title":"Validation of RTOG 0813 proximal bronchial tree constraints for pulmonary toxicity with stereotactic body radiation therapy for central non-small cell lung cancer","volume":"107","author":"Manyam","year":"2020","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"3","key":"10.1016\/j.ctro.2025.101079_b0110","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.radonc.2009.03.005","article-title":"Central thoracic lesions treated with hypofractionated stereotactic body radiotherapy","volume":"91","author":"Milano","year":"2009","journal-title":"Radiother. Oncol."},{"issue":"4","key":"10.1016\/j.ctro.2025.101079_b0115","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.ijrobp.2020.06.068","article-title":"Protecting the heart: a practical approach to account for the full extent of heart motion in radiation therapy planning","volume":"108","author":"Vasquez Osorio","year":"2020","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"1","key":"10.1016\/j.ctro.2025.101079_b0120","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1016\/j.prro.2024.07.010","volume":"15","author":"Ritter","year":"2025","journal-title":"Pract. Radiat. Oncol."},{"key":"10.1016\/j.ctro.2025.101079_b0125","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.radonc.2022.04.005","article-title":"Thorough design and pre-trial quality assurance (QA) decrease dosimetric impact of delineation and dose planning variability in the STRICTLUNG and STARLUNG trials for stereotactic body radiotherapy (SBRT) of central and ultra-central lung tumours","volume":"171","author":"Hoffmann","year":"2022","journal-title":"Radiother. Oncol."},{"issue":"7","key":"10.1016\/j.ctro.2025.101079_b0135","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1002\/cncr.20539","article-title":"Stereotactic hypofractionated high\u2010dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study","volume":"101","author":"Onishi","year":"2004","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.ctro.2025.101079_b0140","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.ijrobp.2008.08.001","article-title":"Stereotactic body radiation therapy in centrally and superiorly located stage I or isolated recurrent non-small-cell lung cancer","volume":"72","author":"Chang","year":"2008","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"7","key":"10.1016\/j.ctro.2025.101079_b0145","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.jtho.2021.03.019","article-title":"The HILUS-trial\u2014a prospective nordic multicenter phase 2 study of ultracentral lung tumors treated with stereotactic body radiotherapy","volume":"16","author":"Lindberg","year":"2021","journal-title":"J. Thorac. Oncol."},{"issue":"3","key":"10.1016\/j.ctro.2025.101079_b0150","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.ijrobp.2024.03.050","article-title":"Stereotactic radiation for ultra-central non-small cell lung cancer: a safety and efficacy trial (SUNSET)","volume":"120","author":"Giuliani","year":"2024","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"15","key":"10.1016\/j.ctro.2025.101079_b0155","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1200\/JCO.18.00622","article-title":"Safety and Efficacy of a Five-Fraction Stereotactic Body Radiotherapy Schedule for Centrally Located Non-Small-Cell Lung Cancer: NRG Oncology\/RTOG 0813 Trial","volume":"37","author":"Bezjak","year":"2019","journal-title":"J. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.ctro.2025.101079_b0160","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.jtho.2016.03.008","article-title":"Outcomes of hypofractionated high-dose radiotherapy in poor-risk patients with \u201cultracentral\u201d non\u2013small cell lung cancer","volume":"11","author":"Tekatli","year":"2016","journal-title":"J. Thorac. Oncol."},{"issue":"8","key":"10.1016\/j.ctro.2025.101079_b0165","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1080\/0284186X.2021.1942545","article-title":"Ultra-central lung tumors: safety and efficacy of protracted stereotactic body radiotherapy","volume":"60","author":"Lodeweges","year":"2021","journal-title":"Acta Oncol."},{"issue":"3","key":"10.1016\/j.ctro.2025.101079_b0170","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.prro.2024.09.012","article-title":"Stereotactic body radiation therapy for primary lung cancer and metastases: a case-based discussion on challenging cases","volume":"15","author":"Ladbury","year":"2025","journal-title":"Pract. Radiat. Oncol."},{"key":"10.1016\/j.ctro.2025.101079_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2023.107281","article-title":"Stereotactic body radiotherapy for Ultra-Central lung Tumors: A systematic review and Meta-Analysis and International Stereotactic Radiosurgery Society practice guidelines","volume":"182","author":"Yan","year":"2023","journal-title":"Lung Cancer"},{"issue":"1","key":"10.1016\/j.ctro.2025.101079_b0180","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s13014-022-02070-x","article-title":"Magnetic resonance guided adaptive stereotactic body radiotherapy for lung tumors in ultracentral location: the MAGELLAN trial (ARO 2021-3)","volume":"17","author":"Regnery","year":"2022","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.ctro.2025.101079_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.110034","article-title":"Widening the therapeutic window for central and ultra-central thoracic oligometastatic disease with stereotactic MR-guided adaptive radiation therapy (SMART)","volume":"190","author":"Lee","year":"2024","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.ctro.2025.101079_b0190","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.radonc.2021.03.001","article-title":"Ablative radiotherapy for ultracentral lung cancers: Dosimetric, geometric, and volumetric predictors of outcomes and toxicity","volume":"158","author":"Breen","year":"2021","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.ctro.2025.101079_b0195","article-title":"Should organs at risk (OARs) be prioritized over target volume coverage in stereotactic ablative radiotherapy (SABR) for oligometastases? a secondary analysis of the population-based phase II SABR-5 trial","volume":"182","author":"Cereno","year":"2023","journal-title":"Radiother. Oncol."}],"container-title":["Clinical and Translational Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630825001715?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630825001715?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T12:22:08Z","timestamp":1770034928000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405630825001715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":37,"alternative-id":["S2405630825001715"],"URL":"https:\/\/doi.org\/10.1016\/j.ctro.2025.101079","relation":{},"ISSN":["2405-6308"],"issn-type":[{"value":"2405-6308","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of tumour proximity to organs-at-risk in adaptive MR-guided SBRT for central lung tumours and metastases","name":"articletitle","label":"Article Title"},{"value":"Clinical and Translational Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctro.2025.101079","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.","name":"copyright","label":"Copyright"}],"article-number":"101079"}}